UAE – The United Arab Emirates will be hosting the Middle East’s first Transplant Oncology Conference on 20th May 2023 at the Conrad Abu Dhabi Etihad Towers.
Transplant Oncology Conference 2023, which is the first-of-its-kind event in the Middle East, will be held in a hybrid mode as it can be accessed by both in-person participants and virtual participants.
Under the patronage of His Excellency Sheikh Nahyan bin Mubarak Al Nahyan, a Cabinet member and the Minister of Tolerance and Coexistence, the conference will focus on transplant oncology.
The application of oncology, transplant medicine, and surgery to improve patients’ survival and quality of life is the core of transplant oncology.
The upcoming Transplant Oncology Conference is backed by the Emirates Oncology Society, the Saudi Center for Organ Transplantation (SCOT), and Houston Methodist Global Health Care Services.
With accreditation from the Accreditation Council for Continuing Medical Education, the symposium is also endorsed by the Department of Health – Abu Dhabi, and the Kuwait Society for Oncology.
The Gulf Cancer Society and Emirates Health are also supporting Middle East’s first-ever Transplant Oncology Conference.
This one-day event under the theme ‘Evolving Field in Cancer Care’ will focus on a novel concept of cancer treatment that combines the fields of transplantation and oncology.
It comes at a pivotal time as scientists are utilizing technological innovation to advance hepatobiliary cancer therapy and research, and provide patients a path toward better disease management.
On her part, Cathy Easter, the President and Chief Executive Officer of Houston Methodist Global, asserted: “With a unique mix of experience, expertise, and multidisciplinary strength, Houston Methodist is a leader in this emerging field.”
She emphasized that the field of transplant oncology has the potential to significantly improve patient survival rates and quality of life.
“In partnership with Emirates Oncology Society, Houston Methodist is honored to bring together specialists in this innovative and promising area,” stated Cathy Easter.
The forthcoming event will serve as an excellent opportunity for participants had the opportunity to exchange knowledge about different types of stem cell transplants.
The event offers a chance for regionally and internationally renowned speakers in the oncology field to engage on how to improve health outcomes and accelerate the development of a potential cure.
Commenting on the significance of this conference Dr. Humaid Al Shamsi, President of the Emirates Oncology Society said: “We are thrilled to announce the launch of the first-ever Transplant Oncology Conference in the Middle East and North Africa (MENA) region.”
“The field of transplant oncology is rapidly advancing. We are dedicated to providing this cutting-edge cancer treatment modality to our patients in the UAE and the wider MENA region,” outlined Dr. Humaid Al Shamsi.
“Our partnership with Houston Methodist is a significant milestone in advancing the field of transplant oncology and learning from their extensive expertise,” underscored Dr. Al Shamsi.
Additionally, several medical experts will deliver industry briefings on liver transplantation for hepatocellular carcinoma, cholangiocarcinoma, colorectal, and neuroendocrine liver metastases.
Participants will also gain insights into cancer recurrence after liver transplantation and the role of novel chemotherapeutic and biological therapy agents in improving transplantation outcomes.
Middle East’s first-ever Transplant Oncology Conference presents a chance for speakers to highlight the applications of ctDNA in the field of transplant oncology.
It is expected to gather global specialists and opinion leaders in transplant oncology, radiology, surgery, hepatology, and immunology.
They are set to debate the boundaries and prospects of the multidisciplinary care of hepatobiliary malignancies.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.